Eli Lilly & Co. (LLY)
1032.60
-40.69
(-3.79%)
USD |
NYSE |
Jan 15, 13:44
Eli Lilly Market Cap: 924.20B for Jan. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 179.04B |
| Regeneron Pharmaceuticals, Inc. | 78.45B |
| Adverum Biotechnologies, Inc. | 96.26M |
| Viking Therapeutics, Inc. | 3.709B |
| Moderna, Inc. | 15.96B |
Market Cap Related Metrics
| PE Ratio | 51.07 |
| PS Ratio | 15.84 |
| PEG Ratio | 0.4214 |
| Price to Book Value | 38.84 |
| Price to Free Cash Flow | 146.26 |
| Price | 1032.60 |
| Earnings Yield | 1.96% |
| PEGY Ratio | 0.4195 |
| Operating PE Ratio | 35.67 |
| Normalized PE Ratio | 45.73 |